GL1X · GenesisL1 explorer

UniProt Q38834

Disease resistance RPP13-like protein 4 (Q38834)

Disease resistance RPP13-like protein 4 (UniProt Q38834): 10 experimental structures and 1 predicted model on GenesisL1, 2 ligands bound, 75 pockets. Binding sites, druggability and experiment against prediction (TM-score) in…

UniProt
Q38834
Protein
Disease resistance RPP13-like protein 4
Experimental structures
10
Predicted models
1
Ligands
2
Pockets
75 · 5 records with a druggable one

Structures

11 records of Q38834 in the MolNFT archive: 10 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
6J5TReconstitution and structure of a plant NLR resistosome conferring immunityelectron microscopyG, C, F, L, ODTP19 (best 0.84)
6J5TReconstitution and structure of a plant nlr resistosome conferring immunityelectron microscopyG, C, F, L, ODTP—
6J5ULigand-triggered allosteric ADP release primes a plant NLR complexelectron microscopyA——
6J5ULigand-triggered allosteric ADP release primes a plant nlr complexelectron microscopyA——
6J5VLigand-triggered allosteric ADP release primes a plant NLR complexelectron microscopyA—16 (best 0.79)
6J5VLigand-triggered allosteric ADP release primes a plant nlr complexelectron microscopyA——
6J5WLigand-triggered allosteric ADP release primes a plant NLR complexelectron microscopyAADP14 (best 0.83)
6J5WLigand-triggered allosteric ADP release primes a plant nlr complexelectron microscopyAADP—
6J6IReconstitution and structure of a plant NLR resistosome conferring immunityelectron microscopyC, F, G, L, ODTP19 (best 0.84)
6J6IReconstitution and structure of a plant nlr resistosome conferring immunityelectron microscopyC, F, G, L, ODTP—
Q38834AlphaFold monomer V2.0 prediction for disease resistance RPP13-like protein 4 (Q38834)predictedA—7 (best 0.78)

Ligands

  • DTP · 2'-deoxyadenosine 5'-triphosphate · in 4 records
  • ADP · Adenosine-5'-diphosphate · in 2 records

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.